Health And Medicine
-
Preserving antibiotic arsenal for TB
Clinicians should be cautious about prescribing newer fluoroquinolone antibiotics to patients with TB risk factors; doing so may jeopardize the use of these agents against TB. Read MoreOct 30, 2013
-
Vanderbilt to study use of plasma on LifeFlight
Vanderbilt University Medical Center will participate in a national trial to see if outcomes for critically injured patients with uncontrolled bleeding can be improved by administering plasma to these patients while in flight to the hospital. Read MoreOct 29, 2013
-
Tool predicts risk for developmental delays in early childhood
A non-invasive measure of electrical brain activity in preterm infants predicts cognitive and communication functioning during early childhood, according to a new Vanderbilt University study. Read MoreOct 28, 2013
-
Targets of SIN drive cell division
Vanderbilt researchers have identified a key regulator of cell division. Read MoreOct 25, 2013
-
Grad students help achieve key discovery
A multidisciplinary study conducted by the combined efforts of Vanderbilt University graduate students has led to the first evidence that abnormal messenger RNA export from the nucleus to the cytoplasm can cause human disease. Read MoreOct 24, 2013
-
Glucose control study gives patients new path to health
The IDIOM study is designed to compare how a diet with moderate caloric restriction, alone or with long-acting insulin, affects areas of the brain’s dopamine system that are involved in food intake, reward and the sense of pleasure people get from eating. Read MoreOct 24, 2013
-
Study sheds new light on type 2 diabetes development
Inactivation by oxidative stress of specific transcription factors essential for pancreatic islet beta cell function is a key event in the development of type 2 diabetes, Vanderbilt University researchers and their colleagues have found. Read MoreOct 24, 2013
-
Shining a light on night blindness
Vanderbilt researchers are studying how mutations in the receptor for light, rhodopsin, cause light blindness. Read MoreOct 24, 2013
-
Frisse, Weiner elected to Institute of Medicine
Vanderbilt University’s Betsy Weiner, Ph.D., R.N., senior associate dean for Informatics in the School of Nursing, and Mark Frisse, M.D., MS, MBA, Accenture Professor and director of Regional Informatics, have been elected to the Institute of Medicine (IOM), the organization announced this week. Read MoreOct 21, 2013
-
Institute of Medicine honors Vanderbilt’s Clayton
Ellen Wright Clayton, M.D., J.D., the Craig-Weaver Professor of Pediatrics and professor of Law at Vanderbilt University, has won the David Rall Medal from the Institute of Medicine (IOM) for “exemplary” service to the institute. Read MoreOct 21, 2013
-
Frog-killing fungus paralyzes amphibian immune response
A fungus that is killing frogs and other amphibians around the world releases a toxic factor that disables the amphibian immune response, Vanderbilt University investigators report Oct. 18 in the journal Science. Read MoreOct 17, 2013
-
VUMC joins national stroke prevention research network
Vanderbilt University Medical Center has joined a national network funded by the National Institutes of Health to streamline multi-site clinical trials focused on key interventions in stroke prevention, treatment and recovery. Read MoreOct 17, 2013
-
Fellow tracks post-vaccination bacterial trends
Pediatric Infectious Diseases fellow Annabelle de St. Maurice, M.D., has been awarded a grant to determine the relationship between pneumococcal vaccination and the emergence of certain strains of pneumococcal bacteria not covered by vaccines. Read MoreOct 17, 2013
-
Pharmacogenomic testing costs studied
A research team led by Josh Peterson, M.D., MPH, assistant professor of Biomedical Informatics and Medicine, and John Graves, Ph.D., assistant professor of Preventive Medicine, will study the cost-effectiveness of testing patients’ risk of adverse gene-drug interactions. Read MoreOct 17, 2013
-
New technique tracks breast cancer subtypes, treatment effectiveness
A group of Vanderbilt researchers has used laser technology and a custom-built multiphoton microscope to distinguish breast cancer subtypes and determine if specific therapies are working against the cancer cells in as little as two days. Read MoreOct 17, 2013
-
Relaxin combats insulin resistance
The hormone relaxin may offer a novel approach for treating diet-induced insulin resistance. Read MoreOct 16, 2013
-
Magnesium impacts vitamin D status
Magnesium and vitamin D appear to work together to reduce risk of death from cardiovascular disease and colorectal cancer. Read MoreOct 14, 2013
-
New target for stopping inflammation
Importin alpha 5, a member of a family of proteins that “shuttle” other proteins into the nucleus, is a potential new target for drugs to treat inflammatory diseases. Read MoreOct 11, 2013
-
Student’s neurosurgical fellowship spurs research
Travis Ladner, a third-year student at the Vanderbilt University School of Medicine, has been selected for a 2013 Congress of Neurological Surgeons (CNS) student fellowship award. The award is presented to a medical student every year from a national pool of applicants. Read MoreOct 10, 2013
-
Grant bolsters study of nursing workforce’s future
Vanderbilt University’s Center for Interdisciplinary Health Workforce Studies has been awarded $2.2 million from the Gordon and Betty Moore Foundation to address nursing workforce issues that may impede future health care. Read MoreOct 10, 2013